Fundraising FoxSectoral Asset Management — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Noctrix Health develops clinically validated wearable therapeutics for managing chronic neurological disorders, with its first product Nidra receiving FDA De Novo authorization and dedicated CMS HCPCS codes.
Digital HealthMedical DevicesWellness & FitnessPleasanton, US
Shri Raghunathan(Founder)inShriram Raghunathan(Executive Officer, Director)
BoardChau Khuong(Director)inAllan May(Director)Mudit Jain(Director)inTracy Pappas(Director)in
Co-investorsAngelini VenturesBlue Venture FundsJoyance PartnersOrbiMedTreo Ventures, LlcZühlke Ventures+2 more
Phagenesis develops targeted pharyngeal electrical stimulation technology to treat neurogenic dysphagia by restoring neural pathways for safe swallowing.
Deep TechDigital HealthHealthtechMedical Devices
Co-investorsAphelion CapitalInnvotec Ltd.Northern GritstoneEQT Life Sciences
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.